NCT06804148

MYVAL Transcatheter Heart Valve System - Prospective German Multicenter Registry

• Status: Recruiting
• Phase: —
• Study type: Observational
• Enrollment: 2,000 (estimated)
• Sponsor: Prof. Dr. med. Ingo Eitel · Academic / Other
• Sex: All
• Age: 18 Years
• Healthy volunteers: Not accepted

Summary

Rational of the Myval THV - Prospective German Multicenter Registry is to evaluate the performance of this relatively new but very promising TAVR valve in a consecutive real-word, all-comers registry and to assess the long-term durability and efficacy of the Myval THV.

Conditions

• Aortic Valve Stenosis

Interventions

Type	Name	Description
DEVICE	Myval Transcatheter Heart Valve	The Myval TAVR bioprothesis is a balloon-expandable THV developed by Meril Lifesciences, which has novel operator friendly design features to improve deliverability and aid precise deployment.

Timeline

• Start date: 2025-01-01
• Primary completion: 2030-12-01
• Completion: 2030-12-30
• First posted: 2025-02-03
• Last updated: 2025-02-03

Locations

1 site across 1 country: Germany